keyword
https://read.qxmd.com/read/38595841/predictive-value-of-corrected-18-f-fdg-pet-ct-baseline-parameters-for-primary-dlbcl-prognosis-a-single-center-study
#21
JOURNAL ARTICLE
Min Li, Jianpeng Liu, Fangfei Liu, Rongbin Lv, Haowei Bai, Shuyong Liu
Objective  The purpose of this study was to evaluate the prognostic significance of corrected baseline metabolic parameters in fluorodeoxyglucose positron emission tomography imaging ( 18 F-FDG PET/CT) for 3-year progression-free survival (PFS) in patients with primary diffuse large B cell lymphoma (DLBCL). Patients and Methods  Retrospective clinical and pathological data were collected for 199 patients of DLBCL diagnosed between January 2018 and January 2021. All patients underwent 18 F-FDG PET/CT scans without any form of treatment...
March 2024: World Journal of Nuclear Medicine
https://read.qxmd.com/read/38595337/a-nomogram-model-based-on-the-inflammation-immunity-nutrition-score-iins-and-classic-clinical-indicators-for-predicting-prognosis-in-extranodal-natural-killer-t-cell-lymphoma
#22
JOURNAL ARTICLE
Yanxia He, Zhumei Luo, Haoqing Chen, Liqing Ping, Cheng Huang, Yan Gao, Huiqiang Huang
BACKGROUND: Systemic inflammation, immunity, and nutritional status are closely related to patients' outcomes in several kinds of cancers. This study aimed to establish a new nomogram based on inflammation-immunity-nutrition score (IINS) to predict the prognosis of extranodal natural killer/T-cell lymphoma (ENKTL) patients. METHODS: The clinical data of 435 patients with ENTKL were retrospectively reviewed and randomly assigned to training cohort (n=305) and validation cohort (n=131) at a ratio of 7:3...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38594876/outcome-and-feasibility-of-radiotherapy-bridging-in-large-b-cell-lymphoma-patients-receiving-cd19-car-t-in-the-uk
#23
JOURNAL ARTICLE
A Kuhnl, C Roddie, A A Kirkwood, S Chaganti, J Norman, S Lugthart, W Osborne, A Gibb, C Gonzalez Arias, A Latif, B Uttenthal, F Seymour, C Jones, D Springell, J L Brady, T Illidge, A Stevens, E Alexander, L Hawley, N O'Rourke, C Bedi, R Prestwich, J Frew, D Burns, M O'Reilly, R Sanderson, S Sivabalasingham, N G Mikhaeel
Radiotherapy (RT) has potential synergistic effects with chimeric antigen receptor (CAR) T but is not widely used as bridging therapy due to logistical challenges and lack of standardised protocols. We analysed RT bridging in a multicentre national cohort of large B-cell lymphoma patients approved for 3L axicabtagene ciloleucel or tisagenlecleucel across 12 UK centres. Of 763 approved patients, 722 were leukapheresed, 717 had data available on bridging therapy. 169/717 (24%) received RT bridging, 129 as single modality and 40 as combined modality treatment (CMT)...
April 9, 2024: British Journal of Haematology
https://read.qxmd.com/read/38589958/swine-acute-diarrhea-syndrome-coronavirus-nsp1-suppresses-ifn-%C3%AE-1-production-by-degrading-irf1-via-ubiquitin-proteasome-pathway
#24
JOURNAL ARTICLE
Chunhui Zhong, Gaoli She, Yukun Zhao, Yufang Liu, Jingmin Li, Xiaona Wei, Zexin Chen, Keyu Zhao, Zhiqing Zhao, Zhichao Xu, Hao Zhang, Yongchang Cao, Chunyi Xue
Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a novel porcine enteric coronavirus that causes acute watery diarrhea, vomiting, and dehydration in newborn piglets. The type III interferon (IFN-λ) response serves as the primary defense against viruses that replicate in intestinal epithelial cells. However, there is currently no information available on how SADS-CoV modulates the production of IFN-λ. In this study, we utilized IPI-FX cells (a cell line of porcine ileum epithelium) as an in vitro model to investigate the potential immune evasion strategies employed by SADS-CoV against the IFN-λ response...
April 8, 2024: Veterinary Research
https://read.qxmd.com/read/38554189/the-effect-of-metabolic-syndrome-on-prognosis-of-diffuse-large-b-cell-lymphoma
#25
JOURNAL ARTICLE
Wenjing Xiong, Liru Li, Xue Hui, Yue Liu, Hongbin Li, Yue Zhang, Shu Zhao
PURPOSE: Metabolic syndrome (MetS), characterized by insulin resistance, is closely associated with the prognosis of various cancer types, but has not been reported in diffuse large B-cell lymphoma (DLBCL). The aim of this study is to examine how other clinicopathological variables and the MetS influence the prognosis of DLBCL. METHODS: Clinical and pathological data were collected from 319 patients with DLBCL who were admitted to our hospital between January 2012 and December 2020...
March 30, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38553068/risk-factors-for-premature-rupture-of-membranes-in-pregnant-women-a-systematic-review-and-meta-analysis
#26
JOURNAL ARTICLE
Danna Lin, Bing Hu, Yuqi Xiu, Ruiting Ji, Huifang Zeng, Hongyan Chen, Yanchun Wu
OBJECTIVE: To identify risk factors for premature rupture of membranes (PROM) in pregnant women. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Web of Science, PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, Chinese Scientific Journal Database (VIP) and China Biology Medicine Disc were searched from inception to October 2022. ELIGIBILITY CRITERIA: Cross-sectional, case-control and cohort studies published in English or Chinese that reported the risk factors for PROM were eligible for inclusion...
March 29, 2024: BMJ Open
https://read.qxmd.com/read/38546551/neoadjuvant-dual-checkpoint-inhibitors-vs-anti-pd1-therapy-in-high-risk-resectable-melanoma-a-pooled-analysis
#27
JOURNAL ARTICLE
Ankit Mangla, Chanmi Lee, Matthew M Mirsky, Margaret Wang, Luke D Rothermel, Richard Hoehn, Jeremy S Bordeaux, Bryan T Carrol, Jason Theuner, Shawn Li, Pingfu Fu, John M Kirkwood
IMPORTANCE: Despite the clear potential benefits of neoadjuvant therapy, the optimal neoadjuvant regimen for patients with high-risk resectable melanoma (HRRM) is not known. OBJECTIVE: To compare the safety and efficacy of dual checkpoint inhibitors with anti-programmed cell death protein-1 (anti-PD1) therapy in a neoadjuvant setting among patients with HRRM. DESIGN, SETTING, AND PARTICIPANTS: In this pooled analysis of clinical trials, studies were selected provided they investigated immune checkpoint inhibitor treatment, were published between January 2018 and March 2023, and were phase 1, 2, or 3 clinical trials...
March 28, 2024: JAMA Oncology
https://read.qxmd.com/read/38545024/clinical-utility-of-cll-ipi-scoring-system-in-pakistani-chronic-lymphocytic-patients-a-single-center-experience
#28
JOURNAL ARTICLE
Aisha Hameed, Nadia Sajid, Muhammad Fayyaz, Shagufta Khaliq
OBJECTIVES: To determine validity of the CLL International prognostic index (IPI) scoring system in Pakistani chronic lymphocytic leukemia patients, as the validity and universal applicability of various prognostic scoring systems such as the CLL-IPI remains a challenge, particularly in under-developed countries like Pakistan. METHODS: This prospective single center study was conducted at Department of Hematology, University of Health Sciences, Lahore and included sixty patients with CLL diagnosed between July, 2019 to July, 2022...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38529375/case-report-a-case-of-metastatic-brafv600-mutated-melanoma-with-heart-failure-treated-with-immune-checkpoint-inhibitors-and-braf-mek-inhibitors
#29
Aya Nishizawa, Misaki Kawakami, Yasuyuki Kitahara
BACKGROUND: Novel therapies, immune checkpoint inhibitors (ICIs), and BRAF/MEK inhibitors (BRAFi/MEKi) provide unprecedented survival benefits for patients with advanced melanoma. However, the management of drug-induced adverse events is problematic for both agents and, although rare, can cause serious cardiac dysfunction. CASE REPORT: A 42-year-old male patient with no significant medical history noticed a fading dark brown patch on his left anterior chest, which had been there for 20 years, after his second coronavirus disease 2019 (COVID-19) vaccination...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38516346/diving-into-cdc-pregnancy-data-in-the-united-states-longitudinal-study-and-interactive-application
#30
JOURNAL ARTICLE
Andrea O Clark-Sevilla, Yun C Lin, Arnav Saxena, Qi Yan, Ronald Wapner, Anita Raja, Itsik Pe'er, Ansaf Salleb-Aouissi
OBJECTIVE: Preterm birth (PTB) is a major determinant of neonatal mortality, morbidity, and childhood disability. In this article, we present a longitudinal analysis of the risk factors associated with PTB and how they have varied over the years: starting from 1968 when the CDC first started, reporting the natality data, up until 2021. Along with this article, we are also releasing an RShiny web application that will allow for easy consumption of this voluminous dataset by the research community...
April 2024: JAMIA Open
https://read.qxmd.com/read/38502889/systemic-therapy-for-advanced-hepatocellular-carcinoma-asco-guideline-update
#31
JOURNAL ARTICLE
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Beal, Richard S Finn, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishmael Jaiyesimi, Minaxi Jhawer, Asha Karippot, Ahmed O Kaseb, R Kate Kelley, Jeremy Kortmansky, Andrea Leaf, William M Remak, Davendra P S Sohal, Tamar H Taddei, Andrea Wilson Woods, Mark Yarchoan, Michal G Rose
PURPOSE: To update an evidence-based guideline to assist in clinical decision-making for patients with advanced hepatocellular carcinoma (HCC). METHODS: ASCO convened an Expert Panel to update the 2020 guideline on systemic therapy for HCC. The panel updated the systematic review to include randomized controlled trials (RCTs) published through October 2023 and updated recommendations. RESULTS: Ten new RCTs met the inclusion criteria and were added to the evidence base...
March 19, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38492885/neural-mechanisms-of-the-temporal-response-of-cortical-neurons-to-intracortical-microstimulation
#32
JOURNAL ARTICLE
Karthik Kumaravelu, Warren M Grill
BACKGROUND: Intracortical microstimulation (ICMS) is used to map neuronal circuitry in the brain and restore lost sensory function, including vision, hearing, and somatosensation. The temporal response of cortical neurons to single pulse ICMS is remarkably stereotyped and comprises short latency excitation followed by prolonged inhibition and, in some cases, rebound excitation. However, the neural origin of the different response components to ICMS are poorly understood, and the interactions between the three response components during trains of ICMS pulses remains unclear...
March 14, 2024: Brain Stimulation
https://read.qxmd.com/read/38485822/adding-myc-bcl2-double-expression-to-nccn-ipi-may-not-improve-prognostic-value-to-an-acceptable-level
#33
JOURNAL ARTICLE
Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai, Suporn Chuncharunee
BACKGROUND: MYC/BCL2 double expression (DE) is associated with poor prognosis in patients with diffuse large B-cell lymphoma (DLBCL) receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). This study aimed to determine whether the addition of DE to the National Comprehensive Cancer Network Internal Prognostic Index (NCCN-IPI) could improve the prediction of disease progression in patients with DLBCL treated with R-CHOP. METHODS: This confirmatory prognostic factor study retrospectively recruited patients with newly diagnosed DLBCL between January 1, 2014, and January 31, 2018, at Ramathibodi Hospital (RA) and Thammasat University Hospital (TU)...
February 19, 2024: Blood Research
https://read.qxmd.com/read/38484278/epis-ri-indonesian-translation-cultural-adaptation-and-construct-validation-of-an-interprofessional-identity-measure
#34
JOURNAL ARTICLE
Fatikhu Yatuni Asmara, Tri Nur Kristina, Marco Versluis, Nynke Scherpbier, Jan Jaap Reinders
Interprofessional Education (IPE) as a preparatory stage for Interprofessional collaboration (IPC) is overlooked in some low-and middle-income countries, including Indonesia. One of the driving forces behind IPC is the development of Interprofessional Identity (IPI), which has yet to be assessed in the Indonesian context. Our study aims were translating and culturally adapting the Extended Professional Identity Scale (EPIS) and confirming its construct validity. We invited third-year students from three programs (medicine, nursing, and dietetics) without previous IPE experience to participate in the study...
March 14, 2024: Journal of Interprofessional Care
https://read.qxmd.com/read/38473456/the-microstructure-and-thermal-conductive-behavior-of-three-dimensional-carbon-carbon-composites-with-ultrahigh-thermal-conductivity
#35
JOURNAL ARTICLE
Baoliu Li, Chenyu Zhu, Huitao Xu, Yudan Qin, Changchun Shan, Fang Gao, Jianguang Guo, Zhijun Dong, Xuanke Li
Carbon-based composite materials, denoted as C/C composites and possessing high thermal conductivity, were synthesized utilizing a three-dimensional (3D) preform methodology. This involved the orthogonal weaving of mesophase pitch-based fibers in an X (Y) direction derived from low-temperature carbonization, and commercial PAN-based carbon fibers in a Z direction. The 3D preforms were saturated with mesophase pitch in their raw state through a hot-pressing process, which was executed under relatively low pressure at a predetermined temperature...
February 20, 2024: Materials
https://read.qxmd.com/read/38467921/-18-f-fdg-pet-ct-for-prognosis-and-toxicity-prediction-of-diffuse-large-b-cell-lymphoma-patients-with-chimeric-antigen-receptor-t-cell-therapy
#36
JOURNAL ARTICLE
Jinbo Gui, Mengting Li, Jia Xu, Xiao Zhang, Heng Mei, Xiaoli Lan
PURPOSE: Chimeric antigen receptor (CAR) T-cell therapy has been confirmed to benefit patients with relapsed and/or refractory diffuse large B-cell lymphoma (DLBCL). It is important to provide precise and timely predictions of the efficacy and toxicity of CAR T-cell therapy. In this study, we evaluated the value of [18 F]fluorodeoxyglucose positron emission tomography/computed tomography ([18 F]FDG PET/CT) combining with clinical indices and laboratory indicators in predicting outcomes and toxicity of anti-CD19 CAR T-cell therapy for DLBCL patients...
March 12, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38467476/immediate-pharmacotherapy-intensification-after-cardiac-resynchronization-therapy-incidence-characteristics-and-impact
#37
JOURNAL ARTICLE
Kojiro Ogawa, Hiro Yamasaki, Kazutaka Aonuma, Masafumi Otani, Ai Hattori, Masako Baba, Kentaro Yoshida, Miyako Igarashi, Hidetaka Nishina, Kou Suzuki, Akihiko Nogami, Masaki Ieda
AIMS: Cardiac resynchronization therapy (CRT) is an established treatment for drug-refractory heart failure (HF) in patients with left bundle branch block (LBBB). Acute haemodynamic improvement after CRT implantation may enable the intensification of HF medication soon thereafter. Immediate pharmacotherapy intensification (IPI) after CRT implantation achieves a synergetic effect, possibly leading to a better prognosis. This study aimed to explore the incidence, characteristics, and impact of IPI on real-world outcomes among CRT recipients with a history of hospitalization for acute HF...
March 11, 2024: ESC Heart Failure
https://read.qxmd.com/read/38462571/mutational-immune-microenvironment-and-clinicopathological-profiles-of-diffuse-large-b-cell-lymphoma-and-follicular-lymphoma-with-bcl6-rearrangement
#38
JOURNAL ARTICLE
Joaquim Carreras, Haruka Ikoma, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Yusuke Kondo, Atsushi Ito, Shunsuke Nagase, Hisanobu Miura, Hiroshi Kawada, Giovanna Roncador, Elias Campo, Rifat Hamoudi, Naoya Nakamura
BCL6-rearrangement (BCL6-R) is associated with a favorable prognosis of follicular lymphoma (FL), but the mechanism is unknown. We analyzed the clinicopathological, immune microenvironment (immune checkpoint, immuno-oncology markers), and mutational profiles of 10 BCL6-R-positive FL, and 19 BCL6-R-positive diffuse large B-cell lymphoma (DLBCL) cases (both BCL2-R and MYC-R negative). A custom-made panel included 168 genes related to aggressive B-cell lymphomas and FL. FL cases were nodal, histological grade 3A in 70%, low Ki67; and had a favorable overall and progression-free survival...
March 11, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38457222/a-single-centre-real-world-study-of-btk-inhibitors-for-the-initial-treatment-of-myd88-mut-cd79b-mut-diffuse-large-b-cell-lymphoma
#39
JOURNAL ARTICLE
Ting Deng, Shiyuan Zhang, Min Xiao, Jia Gu, Liang Huang, Xiaoxi Zhou
BACKGROUND: MCD (MYD88L265P /CD79Bmut ) diffuse large B-cell lymphoma has a poor prognosis. There is no published clinical research conclusion regarding zanubrutinib or orelabrutinib for the initial treatment of MCD DLBCL. AIMS: This study aimed to analyse the efficacy and safety of Bruton's tyrosine kinase inhibitor (BTKi) (zanubrutinib or orelabrutinib) therapy for newly diagnosed DLBCL patients with MYD88mut and/or CD79Bmut . MATERIALS AND METHODS: Twenty-three newly diagnosed DLBCL patients with MYD88mut and/or CD79Bmut from June 2020 to June 2022 received BTKi combined with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) or rituximab + lenalidomide (R2 )...
February 2024: Cancer Medicine
https://read.qxmd.com/read/38451932/prevalence-of-intestinal-parasitic-infections-and-associated-risk-factors-among-patients-attending-debarq-primary-hospital-northwest-ethiopia
#40
JOURNAL ARTICLE
Amir Alelign, Nigus Mulualem, Zinaye Tekeste
Intestinal parasitic infections (IPIs) are major public health problems in developing countries. This study was conducted to determine the prevalence and associated risk factors of IPIs at Debarq Primary Hospital in northwest Ethiopia. A health facility-based cross-sectional study was conducted from March 2022 to June 2022. The study participants were recruited from patients who visited Debarq Primary Hospital during the study period. Stool samples were collected from each participant and examined for intestinal parasites using direct wet-mount and formal-ether concentration techniques...
2024: PloS One
keyword
keyword
8788
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.